![Howard Moore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Howard Moore active positions
Companies | Position | Start | End |
---|---|---|---|
Pictor Ltd.
![]() Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Chief Operating Officer | 2020-08-09 | - |
Chief Executive Officer | - | 2020-08-09 | |
NZeno Ltd.
![]() NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Chairman | 2019-12-31 | - |
Cure Kids Ventures Ltd.
![]() Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Director/Board Member | 2007-12-31 | - |
Career history of Howard Moore
Former positions of Howard Moore
Companies | Position | Start | End |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Founder | 2004-02-29 | 2004-02-29 |
Corporate Officer/Principal | 2004-02-29 | 2004-02-29 |
Training of Howard Moore
Massey University | Undergraduate Degree |
Statistics
International
New Zealand | 5 |
United States | 2 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Cure Kids Ventures Ltd.
![]() Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Finance |
Pictor Ltd.
![]() Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Health Technology |
NZeno Ltd.
![]() NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Health Services |
- Stock Market
- Insiders
- Howard Moore
- Experience